Cargando…

Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2

Protein tyrosine phosphatase SHP2 functions as a key regulator of cell cycle control, and activating mutations cause several cancers. Here, we dissect the energy landscape of wild-type SHP2 and the oncogenic mutation E76K. NMR spectroscopy and X-ray crystallography reveal that wild-type SHP2 exchang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pádua, Ricardo A. P., Sun, Yizhi, Marko, Ingrid, Pitsawong, Warintra, Stiller, John B., Otten, Renee, Kern, Dorothee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207724/ https://www.ncbi.nlm.nih.gov/pubmed/30375376 http://dx.doi.org/10.1038/s41467-018-06814-w

Ejemplares similares

Dynamics of human protein kinase Aurora A linked to drug selectivity
por: Pitsawong, Warintra, et al.
Publicado: (2018)

From primordial clocks to circadian oscillators
por: Pitsawong, Warintra, et al.
Publicado: (2023)

Ancient Origins of Allosteric Activation in a Ser/Thr Kinase
por: Hadzipasic, Adelajda, et al.
Publicado: (2020)

How directed evolution reshapes energy landscapes in enzymes to boost catalysis
por: Otten, Renee, et al.
Publicado: (2020)

An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase
por: Anselmi, Massimiliano, et al.
Publicado: (2020)

Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2
por: Chio, Cynthia M., et al.
Publicado: (2014)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
por: LaRochelle, Jonathan R., et al.
Publicado: (2018)

The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2018)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
por: Ye, Wenjun, et al.
Publicado: (2022)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
por: Calligari, Paolo, et al.
Publicado: (2021)

Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations
por: Wang, Quan, et al.
Publicado: (2020)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function
por: Varone, Alessia, et al.
Publicado: (2021)

The Mechanism of Allosteric Inhibition of Protein Tyrosine Phosphatase 1B
por: Li, Shuai, et al.
Publicado: (2014)

Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
por: Zhu, Yuyu, et al.
Publicado: (2021)

Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012)

Informing Efforts to Develop Nitroreductase for Amine Production
por: Miller, Anne-Frances, et al.
Publicado: (2018)

Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth
por: Wang, Yuyi, et al.
Publicado: (2021)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
por: Markovics, Adrienn, et al.
Publicado: (2020)

A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma
por: Hu, Zhongqian, et al.
Publicado: (2015)

Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2
por: Solman, Maja, et al.
Publicado: (2022)

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020)

Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
por: Gao, Jian, et al.
Publicado: (2022)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Determination of the molecular reach of the protein tyrosine phosphatase SHP-1
por: Clemens, Lara, et al.
Publicado: (2021)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021)

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
por: Pfeiffer, Anamarija, et al.
Publicado: (2022)

The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters
por: Qian, Yueping K, et al.
Publicado: (2008)

Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
por: Liu, Xia, et al.
Publicado: (2011)

Role of the Protein Tyrosine Phosphatase Shp2 in Homeostasis of the Intestinal Epithelium
por: Yamashita, Hironori, et al.
Publicado: (2014)

Novel Functions of the Phosphatase SHP2 in the DNA Replication and Damage Checkpoints
por: Tsang, Yiu Huen, et al.
Publicado: (2012)

Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
por: Chen, Chuan, et al.
Publicado: (2015)

SHP2 phosphatase as a novel therapeutic target for melanoma treatment
por: Zhang, Ruo-Yu, et al.
Publicado: (2016)

Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma
por: Hu, Zhongqian, et al.
Publicado: (2017)

Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in Sepsis
por: Heun, Yvonn, et al.
Publicado: (2019)

The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis
por: Li, Yang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d1beirbekhp94nv2kck7u5pdtm